5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.
about
Serotonin 5-HT7 receptor agents: Structure-activity relationships and potential therapeutic applications in central nervous system disordersAmisulpride is a potent 5-HT7 antagonist: relevance for antidepressant actions in vivoCitalopram increases the differentiation efficacy of bone marrow mesenchymal stem cells into neuronal-like cells.Serotonin receptor subtype and p11 mRNA expression in stress-relevant brain regions of suicide and control subjectsA Case Report of Probable Paliperidone ER-Induced Serotonin Syndrome in a 17-Year-Old Taiwanese Female With New Onset PsychosisAssessing the neuronal serotonergic target-based antidepressant stratagem: impact of in vivo interaction studies and knockout modelsBi-directional modulation of bed nucleus of stria terminalis neurons by 5-HT: molecular expression and functional properties of excitatory 5-HT receptor subtypes.Brain and disease: the long path to discovery and treatment.The preclinical profile of lurasidone: clinical relevance for the treatment of schizophrenia.Five potential therapeutic agents as antidepressants: a brief review and future directions.Phe369(7.38) at human 5-HT(7) receptors confers interspecies selectivity to antagonists and partial agonists.Serotonin 5-HT(7) receptor blockade reverses behavioral abnormalities in PACAP-deficient mice and receptor activation promotes neurite extension in primary embryonic hippocampal neurons: therapeutic implications for psychiatric disorders.Criticisms of drugs in early development for the treatment of depression: what can be improved?Electrical stimulation of the motor cortex enhances progenitor cell migration in the adult rat brain.Arylsulfonamide derivatives of (aryloxy)ethylpiperidines as selective 5-HT7 receptor antagonists and their psychotropic properties
P2860
Q24632508-6E1E2E6E-AE39-462D-BFB5-8A30094419EEQ24647996-87BC6BC1-2672-4F45-90FE-64420CFCB861Q34096097-DBDEF9F3-50F8-4273-AA62-6174CC8DACC3Q36491567-04CD8ADF-BA4B-41A6-94C8-AC48EECE9F8CQ36664013-60B521FF-6376-48EF-A582-30967837F257Q37206280-7373EC93-EDC9-4151-AE0F-1EBAF8F91C7BQ37440533-A1C9F24C-641B-401B-BFEA-264F997CE6D7Q37601168-61A94598-FDE0-4702-8DBE-206D5BFEE269Q38120295-36B401B1-E14A-4ECE-A595-3E5C872C8529Q38574831-A15B2750-DDBD-4DDE-B0FE-3B29B34730FFQ39640436-97252CEC-6F37-42FC-B5A0-6FA87C830F87Q47970781-B1599D83-1695-4641-83A0-8F007C996FF8Q48148268-16D0FA96-4397-488E-9321-0174FDA0EA47Q49078378-5EC5CD9F-8241-4241-9278-057E94D5FFF9Q56980032-A943CF1E-18AD-4162-B261-C00EF2555246
P2860
5-HT7, neurogenesis and antidepressants: a promising therapeutic axis for treating depression.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
5-HT7, neurogenesis and antide ...... axis for treating depression.
@ast
5-HT7, neurogenesis and antide ...... axis for treating depression.
@en
type
label
5-HT7, neurogenesis and antide ...... axis for treating depression.
@ast
5-HT7, neurogenesis and antide ...... axis for treating depression.
@en
prefLabel
5-HT7, neurogenesis and antide ...... axis for treating depression.
@ast
5-HT7, neurogenesis and antide ...... axis for treating depression.
@en
P2093
P2860
P1476
5-HT7, neurogenesis and antide ...... axis for treating depression.
@en
P2093
Dhanisha Jhaveri
L Sanjay Nandam
Perry Bartlett
P2860
P304
P356
10.1111/J.1440-1681.2007.04608.X
P577
2007-05-01T00:00:00Z